HWAM
ANAB icon

Hennion & Walsh Asset Management’s AnaptysBio ANAB Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,118
Closed -$735K – 746
2021
Q3 		$735K Sell
27,118
-1,171
-4% -$29.7K 0.04% 423
2021
Q2 		$734K Sell
28,289
-15,074
-35% -$361K 0.04% 429
2021
Q1 		$934K Buy
+43,363
New +$1.09M 0.06% 370

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Hennion & Walsh Asset Management's ANAB Position: Q4 2021 in Review

Hennion & Walsh Asset Management sold out of AnaptysBio (ANAB) in Q4 2021, closing a stake of 27,118 shares — an estimated $735K sold.

Hennion & Walsh Asset Management first reported a position in ANAB in Q1 2021 and held it in 3 quarters. The position peaked at $934K in Q1 2021. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2021.

  • Hennion & Walsh Asset Management reported no remaining AnaptysBio position as of Q4 2021 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 27,118 AnaptysBio shares in Q4 2021, an estimated $735K.
  • Hennion & Walsh Asset Management first reported a position in AnaptysBio in Q1 2021 and held it in 3 quarters.
  • Hennion & Walsh Asset Management's AnaptysBio position peaked at $934K in Q1 2021.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2021.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.